RenJi Hospital: Breast Neoplasms trials

The registry lists 18 Breast Neoplasms studies with RenJi Hospital as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 6Phase 3 3No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)RecruitingNCT07283692Phase 2
• Target-specific immunoPET Imaging of Breast CancerRecruitingNCT06715826Phase 1/2
• Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA)Not yet recruitingNCT06510465Phase 2
• A Simplified Approach to Predicting the Malignancy of Breast Lesions: Nomogram in UltrasonographyNot yet recruitingNCT06185855
• Disitamab Vedotin (RC48-ADC) in Breast CancerRecruitingNCT05851677
• CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast CancerRecruitingNCT05795335
• Pre-operative Therapy in Breast CancerRecruitingNCT05621564
• CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical TrialRecruitingNCT05360290Not applicable
• Early Detection of CMP in Patients With Breast Cancer Using Cardiac Magnetic ResonanceRecruitingNCT04510532
• Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk WomenRecruitingNCT03201861Phase 3
• Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast CancerActive, not recruitingNCT03982485Phase 2
• CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical TrialCompletedNCT03732339Not applicable
• A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After SurgeryCompletedNCT03109990Not applicable
• Effects of Dexmedetomidine on Breast Cancer Cell Function in VitroCompletedNCT03108937Not applicable
• Accurate Diagnosis System for Postoperative Chronic Pain Based on fMRIStatus unknownNCT03022864
• Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant ChemotherapyStatus unknownNCT02879513Phase 3
• Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer PatientsActive, not recruitingNCT02221999Phase 2/3
• Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast CancerCompletedNCT02199418Phase 2